Cellromax Science Co., Ltd. (KOSDAQ: A471820)
Financials · Capital Markets · KR
₩4,080.00
-0.97% today · -22.7% 1Y
Cellromax Science Co., Ltd. (KOSDAQ: A471820) operates in the Capital Markets industry within the Financials sector. The company is valued at $33.88M.
Over the last twelve months the share price has lost 22.7%, trading between 3.41K and 7.69K.
Tweenvest scores Cellromax Science Co., Ltd. across four factors: quality 91/100, value 39/100, dividend 100/100. Its strongest factor is dividend.
A471820 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.88M
- Revenue (TTM)
- $12.66M
- P/E
- 14.95
- EPS
- 272.90
- Dividend yield
- 4.53%
- Beta (5Y)
- —
- 52-week high
- ₩7,690.00
- 52-week low
- ₩3,410.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.16M
- Employees
- —
- Next earnings
- —
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NeuroMind AI Corp.OTCPK: GGAA.F | $34.10M | $— | — |
| Chernomorski Holding ADBUL: CHL | $33.99M | €— | — |
| Finansia X Public Company LimitedSET: FSX | $33.95M | ฿1.00 | +7.53% |
| AKKO Invest Nyrt.BUSE: AKKO | $33.89M | Ft238.00 | +0.85% |
| Corporate Merchant Bankers LimitedBSE: 540199 | $33.75M | Rs51.55 | +5.29% |
| Hedef Girisim Sermayesi Yatirim Ortakligi A.S.IBSE: HDFGS | $33.44M | TL1.46 | +50.52% |
| DG-Gruppe AGHMSE: DG6 | $33.39M | €— | — |
| Allerthal-Werke AGBST: ATW | $32.78M | €24.40 | -0.81% |
Figures last refreshed Oct 11, 2026.